Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952365 · ClinicalTrials.gov registry record · Phase 4
Tissue Sealant Use in LASIK Enhancement Surgery
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02952365: Completed Phase 4 study, sponsored by Stanford University.
NCT02952365 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02952365, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery
Interventions
- DRUG Tissue sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2017-05-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02952365
The ClinicalTrials.gov registry entry for NCT02952365 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tissue sealant is the first listed.
NCT02952365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02952365 about?
NCT02952365 is a clinical study titled "Tissue Sealant Use in LASIK Enhancement Surgery". The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery
What is the current status of trial NCT02952365?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2016-10-01. Estimated completion is 2017-05-22.
What interventions are being tested in trial NCT02952365?
The interventions under investigation include: Tissue sealant (DRUG).
Who is sponsoring clinical trial NCT02952365?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.